1h Free Analyst Time
The organ preservation market is forecasted to grow by USD 106.96 million during 2022-2027, accelerating at a CAGR of 6.91% during the forecast period. The report on the organ preservation market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing demand for organ transplants, advancements in preservation techniques, and increasing awareness of organ donation and donor programs.
The organ preservation market is segmented as below:
By Type
- Living organ donation
- Deceased organ donation
By End-user
- Hospitals and clinics
- Organ banks
- Others
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the organ preservation market covers the following areas:
- Organ preservation market sizing
- Organ preservation market forecast
- Organ preservation market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Type
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global organ preservation market: 21st Century Medicine, Accord Healthcare Ltd., Biochefa Pharmaceutical Research And Production Plant Ltd., BioLife Solutions Inc., Bridge to Life Ltd., Carnamedica, dr. Franz Koehler Chemie GmbH, EBERS MEDICAL TECHNOLOGY SL, Global Transplant Solutions, Organ Recovery Systems Inc., OrganOx Ltd., Paragonix Technologies Inc., Preservation Solution Inc., Revive Organtech Inc., SALF SpA, Stellantis NV, TransMedics Inc., TX Innovations, Waters Medical Systems LLC , and XVIVO Perfusion AB.Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is increasing prominence of normothermic perfusion systems."
According to the report, one of the major drivers for this market is the growing demand for organ transplants.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 21st Century Medicine
- Accord Healthcare Ltd.
- Biochefa Pharmaceutical Research And Production Plant Ltd.
- BioLife Solutions Inc.
- Bridge to Life Ltd.
- Carnamedica
- dr. Franz Koehler Chemie GmbH
- EBERS MEDICAL TECHNOLOGY SL
- Global Transplant Solutions
- Organ Recovery Systems Inc.
- OrganOx Ltd.
- Paragonix Technologies Inc.
- Preservation Solution Inc.
- Revive Organtech Inc.
- SALF SpA
- Stellantis NV
- TransMedics Inc.
- TX Innovations
- Waters Medical Systems LLC
- XVIVO Perfusion AB